on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its

office building business 337 384 (47) (12) Other income 269 261 8 3 Total revenues 10,949 16,148 (5,199) (32) In summary, the Company and its subsidiaries generated total revenues for the year ended 2019

 co from  Bt244  t 4.7GB/data su   AIS Fibre cont increased to B higher speed p       Summary d  to  focus  on g data  leadersh gh quality subsc ed  existing  qua 22,843mn  wer   strengthen  attractive

Management Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.15 31.12.16 30.06.17 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,246 1,228 1,279 Total Assets 1,378 1,361 1,407 Current

Management Discussion and Analysis as follows : FINANCIAL SUMMARY 31.12.15 31.12.16 30.09.17 FINANCIAL POSITION (MILLION BAHT) Current Assets 1,246 1,228 1,165 Total Assets 1,378 1,361 1,290 Current

11,497,220 10.02 Purchase from other persons No.of shares Price Amount Shareholding Proportion (shares) (Baht/share) (Baht) (%) Total 1,397 2,870 4,009,390 3.49 (8) Summary of Fame Line Company Limited

, equivalent to 5.7% and 6.3% of total revenue, respectively. Summary of selling and administrative expenses are as follows: Description Selling and Administrative expenses ( THB MB ) Y-O-Y Change Increase

( Miss.Pakatip Lopandhsri ) Director & Senior Vice President Nawarat Patanakarn Public Company Limited (Translation) NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE

clause 4.2 Re: Financial Information Summary of CVHLUX 3/ Consolidated financial statements of CVHLUX show a negative net asset value, therefore, the calculation of net asset value is not applicable

and only holds 100% of the issued and paid- up capital of ICUK for a 9-month period ending 30 September 2017 as mentioned in clause 4.2 Re: Financial Information Summary of CVHLUX 3/ Consolidated